Product Information
CINACALCET HCL 30 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.4022 per EA under NDC 69097041002. Its NADAC has been published 375 times since Jun 19, 2019.
FDA first approved this application on Mar 8, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Cipla USA Inc.NDC
69097041002
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CINACALCET HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208915FDA Approved
3/8/2018
TE Code
AB
On Market Since
3/8/2018
Pharmacological Classes
Price Statistics
The NADAC for CINACALCET HCL 30 MG TABLET has been published 375 times since Jun 19, 2019, and over the history we have for it it has declined 98.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4022 per EA |
|---|---|
| All-time high | $21.2061 (Aug 14, 2019) |
| All-time low | $0.2542 (Nov 20, 2024) |
| 52-week high | $0.4156 |
| 52-week low | $0.3448 |
| Median price | $0.4066 |
| Average price | $3.2997 |
| Largest weekly change | -58.1% (Sep 21, 2022) |
| Weeks tracked | 375 |
| Tracking since | Jun 19, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CINACALCET HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CINACALCET HCL 30 MG TABLET, manufactured by Cipla USA Inc., is $0.4022 per EA (NDC 69097041002), effective Aug 19, 2026.
How has the price of CINACALCET HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for CINACALCET HCL 30 MG TABLET has declined 98.1%. It has been tracked across 375 weekly CMS publications since Jun 19, 2019.
What are the highest and lowest recorded NADAC prices for CINACALCET HCL 30 MG TABLET?
Since Jun 19, 2019, the NADAC for CINACALCET HCL 30 MG TABLET has ranged from a low of $0.2542 (Nov 20, 2024) to a high of $21.2061 (Aug 14, 2019), with a median of $0.4066 per EA.
Are there cheaper alternatives to CINACALCET HCL 30 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CINACALCET HCL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CINACALCET HCL 30 MG TABLET?
CINACALCET HCL 30 MG TABLET (NDC 69097041002) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.